These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 18178151

  • 21. Inhibition of IL-10 protein synthesis induces major histocompatibility complex class II gene expression in class II-deficient patients.
    Hauber I, Wolf HM, Samstag A, Pein B, Kreil TR, Gulle H, Fischer MB, Eibl MM.
    Cell Immunol; 1997 Sep 15; 180(2):95-103. PubMed ID: 9341739
    [Abstract] [Full Text] [Related]

  • 22. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
    Takagi A, Nishiyama C, Kanada S, Niwa Y, Fukuyama K, Ikeda S, Okumura K, Ogawa H.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):388-93. PubMed ID: 16836979
    [Abstract] [Full Text] [Related]

  • 23. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y, Chamuleau ME, van de Loosdrecht AA, Tolosa E, Jorritsma T, Muris JJ, Dinnissen-van Poppel MJ, Snel SN, van de Corput L, Ossenkoppele GJ, Meijer CJ, Neefjes JJ, Marieke van Ham S.
    Br J Haematol; 2009 May 25; 145(3):334-43. PubMed ID: 19245431
    [Abstract] [Full Text] [Related]

  • 24. Chlamydia pneumoniae induces interleukin-10 production that down-regulates major histocompatibility complex class I expression.
    Caspar-Bauguil S, Puissant B, Nazzal D, Lefèvre JC, Thomsen M, Salvayre R, Benoist H.
    J Infect Dis; 2000 Nov 25; 182(5):1394-401. PubMed ID: 11023462
    [Abstract] [Full Text] [Related]

  • 25. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.
    Dziembowska M, Fondaneche MC, Vedrenne J, Barbieri G, Wiszniewski W, Picard C, Cant AJ, Steimle V, Charron D, Alca-Loridan C, Fischer A, Lisowska-Grospierre B.
    Immunogenetics; 2002 Feb 25; 53(10-11):821-9. PubMed ID: 11862382
    [Abstract] [Full Text] [Related]

  • 26. Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells.
    Li H, Liu ZH, Dai CS, Liu D, Li LS.
    Acta Pharmacol Sin; 2002 Sep 25; 23(9):775-81. PubMed ID: 12230943
    [Abstract] [Full Text] [Related]

  • 27. Phorbol myristate acetate-differentiated THP-1 cells display increased levels of MHC class I and class II mRNA and interferon-gamma-inducible tumoricidal activity.
    Asseffa A, Dickson LA, Mohla S, Bremner TA.
    Oncol Res; 1993 Sep 25; 5(1):11-8. PubMed ID: 8396466
    [Abstract] [Full Text] [Related]

  • 28. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B.
    Br J Dermatol; 2008 May 25; 158(5):930-40. PubMed ID: 18284388
    [Abstract] [Full Text] [Related]

  • 29. CIITA transformation rescues the apoptotic function of MHC class II in melanoma cells.
    Le E, Zhang H, Blanck G.
    Anticancer Res; 2005 May 25; 25(6B):3889-92. PubMed ID: 16312044
    [Abstract] [Full Text] [Related]

  • 30. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta.
    Harnesk K, Swanberg M, Diez M, Olsson T, Piehl F, Lidman O.
    J Neuroimmunol; 2009 Jul 25; 212(1-2):44-52. PubMed ID: 19481818
    [Abstract] [Full Text] [Related]

  • 31. Differential modulatory effect of NGF on MHC class I and class II expression in spinal cord cells of EAE rats.
    Stampachiacchiere B, Aloe L.
    J Neuroimmunol; 2005 Dec 25; 169(1-2):20-30. PubMed ID: 16169604
    [Abstract] [Full Text] [Related]

  • 32. [Inhibition effect of CIITA anti-sense cDNA on the expression of MHCII molecules of Hela cells].
    Guo R, Zou P, Fan HH, Cui L, Cao YL, Zheng B, Gao L, Gao F, Lu HZ.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec 25; 24(12):636-9. PubMed ID: 14761611
    [Abstract] [Full Text] [Related]

  • 33. Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis.
    Cross A, Bucknall RC, Cassatella MA, Edwards SW, Moots RJ.
    Arthritis Rheum; 2003 Oct 25; 48(10):2796-806. PubMed ID: 14558085
    [Abstract] [Full Text] [Related]

  • 34. Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes.
    Pollack BP, Sapkota B, Cartee TV.
    Clin Cancer Res; 2011 Jul 01; 17(13):4400-13. PubMed ID: 21586626
    [Abstract] [Full Text] [Related]

  • 35. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice.
    Jabrane-Ferrat N, Campbell MJ, Esserman LJ, Peterlin BM.
    Cancer Gene Ther; 2006 Nov 01; 13(11):1002-10. PubMed ID: 16841083
    [Abstract] [Full Text] [Related]

  • 36. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb 01; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 37. Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.
    Kuipers HF, Biesta PJ, Groothuis TA, Neefjes JJ, Mommaas AM, van den Elsen PJ.
    Hum Immunol; 2005 Jun 01; 66(6):653-65. PubMed ID: 15993711
    [Abstract] [Full Text] [Related]

  • 38. Regulation of MHC class II gene expression by the class II transactivator.
    Reith W, LeibundGut-Landmann S, Waldburger JM.
    Nat Rev Immunol; 2005 Oct 01; 5(10):793-806. PubMed ID: 16200082
    [Abstract] [Full Text] [Related]

  • 39. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S, Kim K, Song Y, Kim H, Kwon J, Lee YH, Lee CK, Lee SJ, Ha N, Kim K.
    Arch Pharm Res; 2008 Mar 01; 31(3):370-6. PubMed ID: 18409052
    [Abstract] [Full Text] [Related]

  • 40. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.
    LeibundGut-Landmann S, Waldburger JM, Krawczyk M, Otten LA, Suter T, Fontana A, Acha-Orbea H, Reith W.
    Eur J Immunol; 2004 Jun 01; 34(6):1513-25. PubMed ID: 15162420
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.